Daily Derm Times: April 25, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care

Discover how the RAD conference in Nashville enhances atopic dermatitis care, featuring expert insights and patient-focused strategies for clinicians.

FDA Places Clinical Hold on VYNE’s VYN202 Phase 1b Trial for Plaque Psoriasis

VYNE Therapeutics paused its VYN202 trial for psoriasis due to an FDA-issued clinical hold.

Deuruxolitinib is Most Effective Monotherapy for Alopecia, According to Meta-Analysis

A recent meta-analysis evaluates the efficacy and safety of various JAK inhibitors for alopecia areata, highlighting 12 mg twice daily deuruxolitinib as the most effective treatment.

Hyaluronic Acid Boosts Results in Rosacea Management

Discover innovative rosacea treatments combining injectable hyaluronic acid with traditional therapies to enhance skin health and boost patient confidence.

Can Colloidal Oat Emollients Be Used to Treat Pediatric Atopic Dermatitis?

Sophisticated colloidal oat emollients show promise in effectively managing pediatric atopic dermatitis, enhancing skin hydration and reducing flare-ups in infants.

Xerosis Management: Back to Basics with Emollients

Explore the effectiveness of basic emollients in treating xerosis cutis associated with atopic dermatitis, enhancing skin hydration and barrier function.